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Abstract
Background: Intranasal topical 1:1000 epinephrine has been used safely and effectively for hemostasis during endoscopic
sinus surgery (ESS). Prior studies assessing hemodynamic changes after intranasal topical epinephrine application have
only used soaking wet cottonoid pledgets, and have only assessed for hemodynamic changes before any surgery being
performed.
Objective: The purposes of this study were to determine whether intranasal application of topical 1:1000 epinephrine
with wrung-out cottonoid pledgets caused significant hemodynamic changes both before and during ESS, and whether it
allowed for adequate hemostasis.
Methods: A prospective evaluation of 30 patients with eosinophilic chronic rhinosinusitis with nasal polyps (CRSwNP)
undergoing complete bilateral ESS was conducted. Heart rate, blood pressure (systolic, diastolic, and mean arterial
pressure), and electrocardiography changes were recorded at 0, 1, 2, and 5-minute intervals after placing wrung-out
epinephrine-saturated pledgets, both before and at the end of ESS. No submucosal epinephrine injections were performed.
Estimated blood loss (EBL) and major intraoperative complications were recorded for all cases.
Results: There were no significant hemodynamic changes or electrocardiographic abnormalities after placement of wrungout epinephrine-soaked pledgets both before and after ESS. After bilateral ESS, there were actually mean decreases in heart
rate and blood pressure parameters. Mean EBL was 75.8 ± 32.2 mL, and no major intraoperative complications occurred.
Conclusion: Intranasal application of topical 1:1000 epinephrine via wrung-out cottonoid pledgets was effective for
intraoperative hemostasis, and did not cause clinically significant alterations in hemodynamic parameters or cardiovascular
events, either before or during ESS in patients with CRSwNP.
Level of Evidence: 4
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Introduction
Intranasal topical 1:1000 epinephrine is commonly used to
achieve hemostasis and to improve intraoperative visualization during endoscopic sinus surgery (ESS). Epinephrine
can be administered intranasally either by submucosal
injection or by topical mucosal application, commonly
through cottonoid pledgets. Both methods have been shown
to improve hemostasis.1 However, submucosal injection
results in higher plasma epinephrine concentrations than
topically applied epinephrine.2,3 Although rare, submucosal
epinephrine injection is more likely to cause hemodynamic
changes or cardiovascular events compared to topical epinephrine.4-6 Additionally, inadvertent intravascular injection of epinephrine can lead to life-threatening cardiovascular
events,7,8 or even death.9

A number of studies have analyzed the safety of intranasal 1:1000 topical epinephrine, and very few adverse events
have been reported.1,2,4,5,7,10-12 With regard to study designs,
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2
retrospective chart reviews have been limited to reporting
intraoperative and postoperative cardiovascular events, and
while very rare on the order of 0.05%, they do not capture
hemodynamic changes that occur after intranasal topical
epinephrine application.7,10,11 Epinephrine is metabolized
rapidly both locally and systemically,13 so to capture its
effect on hemodynamic parameters after intranasal application, a prospective study measuring parameters in short successive time periods is required. While a few prospective
studies have demonstrated safety with topical epinephrine
application by nasal pledgets,4,6,12 two of the studies actually did show hemodynamic parameter elevations after
placement of completely soaked epinephrine pledgets.6,12
Some authors have recommended wringing out epinephrine-soaked pledgets to minimize potentially dangerous
systemic effects of epinephrine.1,5,10 However, no prospective study has assessed hemodynamic changes after placement of wrung-out pledgets.
These prior studies also only assessed the effects of
topical epinephrine before any sinonasal surgery being
performed.4,6,12 It is possible that exposure of sinonasal
vascular beds during ESS could increase the risk of epinephrine absorption systemically,9 so studying hemodynamic changes after topical epinephrine application during
ESS would be beneficial. The purposes of this study were
to determine whether intranasal application of topical
1:1000 epinephrine with wrung-out pledgets caused significant hemodynamic parameter changes both before and during ESS, and whether it allowed for adequate hemostasis.

Methods
Patient Population
Thirty adult patients who underwent complete bilateral ESS
for eosinophilic chronic rhinosinusitis with nasal polyps
(CRSwNP) were evaluated prospectively for hemodynamic
changes after intranasal application of topical 1:1000 epinephrine before and during surgery. Institutional Review
Board approval was obtained. All CRSwNP patients had
polyps extending into the nasal cavity, and Lund-Mackay
scores were collected. Structured histopathology reports
were analyzed, and tissue eosinophilia was described as
≥10 eosinophils per high-power field.14 Patients with significant cardiovascular disease with New York Heart
Association (NYHA) class 3 or 4 disease, and known
arrhythmias were excluded from the study. Patients were
also excluded if they were pregnant, or if they had allergies
to lidocaine, bupivacaine, or epinephrine.

Experimental Procedure
Topical epinephrine was applied intranasally by 0.5 × 3-inch
cottonoid pledgets (Codman and Shurtleff Inc, Raynham,
MA). Pledgets were first completely soaked by immersing
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10 pledgets at a time in 30 mL of 1:1000 epinephrine for at
least 5 minutes. Pledgets were then wrung out prior to intranasal placement by the senior author (JRC) in a standardized fashion, from one end of the pledget to the other.
Patients received no anesthetic or anxiolytic medication prior
to induction. After induction with fentanyl, lidocaine,
propofol, and rocuronium, patients were intubated, and
their cardiovascular parameters were allowed to stabilize
over 15 minutes. Next, epinephrine-soaked pledgets were
wrung out and placed intranasally before any surgery was
performed. When anatomy permitted, one pledget was
placed into the middle meatus, and another into nasal cavity between the inferior turbinate and nasal septum. When
nasal cavities were obstructed either by nasal polyps or a
deviated septum, pledgets were placed intranasally in
positions to maximize mucosal contact. A total of four
pledgets were always placed preoperatively, two in each
nasal cavity. Note that submucosal injection of epinephrine was never performed.
Patients were then maintained with sevoflurane or isoflurane for
the case duration. Neither nitrous oxide nor vasopressors were
used in any cases. Urine output was maintained at greater than
0.5 mL/kg/hour. Intraoperatively, wrung-out pledgets were
placed into the operated sinus cavities after complete bilateral ESS. All patients underwent the same complete bilateral ESS, which included wide maxillary antrostomies, total
ethmoidectomies with partial middle turbinate resections,
wide sphenoidotomies, and Draf IIB frontal sinusotomies.15
Six pledgets were always placed after completing ESS
bilaterally, three on each side. Pledgets were placed so as to
avoid pledget overlap and maximize contact between pledgets and traumatized tissue. Note that while epinephrine
pledgets were used throughout the case for hemostasis as
needed, no pledgets were placed on either side for at least
15 minutes prior to placement of the pledgets utilized for
hemodynamic measurements. This was done to minimize
the chance of any residual epinephrine locally or systemically from affecting hemodynamic measurements, since the
half-life of epinephrine is 2 to 3 minutes.16

Outcome Measures
The following baseline hemodynamic parameters were
measured preoperatively and intraoperatively, immediately
before pledgets were placed: heart rate (HR), systolic and
diastolic blood pressure (SBP and DBP), mean arterial pressure (MAP), and electrocardiogram (ECG) abnormalities.
Figure 1 demonstrates the timing of hemodynamic measurements from baseline to 1, 2, and 5 minutes, after which
the pledgets were removed from the sinonasal cavities. The
time between pledgets being placed preoperatively and
intraoperatively was recorded for each patient. The type of
maintenance general anesthetic used, and whether the
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Figure 1. Flow diagram illustrating the basic study design of the timing of hemodynamic parameter measurements relative to
intranasal pledget placement, both preoperatively and intraoperatively.
Table 1. Mean Baselines and Changes in Preoperative Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure
(DBP), and Mean Arterial Pressure (MAP) After Placing Wrung-Out Epinephrine Pledgets.
Mean
Mean Change from
Baseline, ±SD Baseline at 1 Min, ±SD P-Value
HR, bpm
SBP, mmHg
DBP, mmHg
MAP, mmHg

75.8 ± 9.9
103.6 ± 14.9
58.2 ± 8.6
76.3 ± 10.8

+1 ± 4.8
+4.7 ± 9.4
+2.8 ± 5.1
+2.9 ± 8.3

.261
.013
.007
.063

Mean Change from
Baseline at 2 Min, ±SD
+1.2 ± 6.2
+0.8 ± 9.3
+1.7 ± 6.1
+0.4 ± 9.2

Mean Change from
P-Value Baseline at 5 Min, ±SD
.297
.649
.151
.828

−1.6 ± 5.8
−0.9 ± 6.4
+0.03 ± 4.9
−0.5 ± 7.5

P-Value
.133
.437
.970
.700

Note. The bold values are statistically significant values.

following medications were utilized during cases were also
recorded: beta-blockers, dexmedetomidine, and remifentanil. No arterial lines were utilized. Estimated blood loss
(EBL) was recorded after every case, and was calculated by
subtracting the known amount of saline irrigation used during surgery from the total amount of blood plus saline irrigation collected in a suction container during surgery. The
following intraoperative complications were recorded as
well: cerebrospinal fluid leak, orbital injury, arterial injury,
or severe hemorrhage requiring blood transfusion. Potential
arterial injuries included direct injuries to the internal
carotid, anterior ethmoid, posterior ethmoid, or sphenopalatine arteries.

Statistical Analysis
Preoperative and intraoperative baseline hemodynamic
parameters were compared. Preoperative hemodynamic
parameters at 1, 2, and 5 minutes after pledget placement
were compared to their baseline measurements, and intraoperative hemodynamic parameters were analyzed in the
same manner. Statistical analysis was carried out using
paired two-tailed student’s t-tests. Separate t-tests were performed to compare the mean preoperative and intraoperative hemodynamic parameter changes between baseline and
1, 2, and 5-minute measurements. Statistical significance
was set at P < .05. All statistical analyzes were performed
using R software (version 3.6.1).
Data from these 30 patients were used to perform a
power analysis using R software (version 3.6.1) and PASS
(16.0.1). For hemodynamic parameters, a change greater

than 20% from the baseline measurements was considered
clinically meaningful. The means of baseline hemodynamic
parameters were estimated from data in this study, and the
minimal clinically meaningful detectable difference for
each hemodynamic parameter was calculated by multiplying mean baseline values by 20%. The standard deviation of
the paired difference was also estimated from study data.
The effect size was calculated as the difference/standard
deviation. Note that because preoperative MAP had the
smallest effect size (1.69) among all hemodynamic parameters, a sample size was sought that would achieve at least
80% power to detect that effect size. A sample size of six
patients was determined to achieve at least 80% power to
reject the null hypothesis of zero effect size when the population effect size was 1.69, and the significance level (alpha)
was 0.05 using a two-sided paired t-test. Therefore, the data
from the current study achieved adequate power, and additional data collection was not needed.

Results
Of the 30 CRSwNP patients, all were eosinophilic, mean
age was 55.4 ± 16 years (Range, 18-80), and 57% were
male. The mean Lund-Mackay score was 20.1 ± 2.2.
The mean elapsed time between preoperative and intraoperative hemodynamic parameter measurements was
132.6 ± 22.4 minutes.
Table 1 shows the hemodynamic parameter changes after
wrung-out epinephrine pledgets were placed preoperatively,
after induction. Topical 1:1000 epinephrine largely led to no
statistically significant alterations in any hemodynamic
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Figure 2. Spaghetti plots demonstrating changes in preoperative heart rate (HR), systolic blood pressure (SBP), diastolic blood
pressure (DBP), and mean arterial pressure (MAP) for all patients after placing wrung-out epinephrine pledgets.
Table 2. Mean Baselines and Changes in Intraoperative Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure
(DBP), and Mean Arterial Pressure (MAP) After Placing Wrung-Out Epinephrine Pledgets.
Mean
Mean Change from
Mean Change from
Mean Change from
Baseline, ±SD Baseline at 1 Min, ±SD P-Value Baseline at 2 Min, ±SD P-Value Baseline at 5 Min, ±SD P-Value
HR, bpm)
SBP, mmHg
DBP, mmHg
MAP, mmHg

81 ± 9.9
114.8 ± 13.2
64 ± 10.8
82.2 ± 10.4

−0.2 ± 3.1
−3.4 ± 9
−1.7 ± 5.2
−1.9 ± 6.7

.771
.047
.077
.123

−1.2 ± 3.7
−6.4 ± 9.8
−4.1 ± 6.2
−4.2 ± 7.8

.098
.001
.001
.006

−3.5 ± 4.9
−11.9 ± 11.9
−8.5 ± 6
−8.6 ± 8.8

.001
<.001
<.001
<.001

Note. The bold values are statistically significant values.

parameters. There were slight transient increases in SBP and
DBP of 4.6 and 2.8 mmHg, respectively, that were statistically significant at 1 minute. However, all parameter changes
were non-significant at 2 and 5 minutes. Figure 2 is a spaghetti plot of all patients’ hemodynamic parameter changes
at successive time points after epinephrine pledgets were
placed preoperatively.
Table 2 shows the hemodynamic parameter changes
after wrung-out epinephrine pledgets were placed intraoperatively, after complete bilateral ESS. Interestingly, all
hemodynamic parameters trended downward at 1, 2, and
5 minutes. Decreases in blood pressure parameters were statistically significant at nearly all time points, except for the
MAP decrease at 1 minute. HR also decreased from baseline at each time point, but was only statistically significant
at 5 minutes. Figure 3 is a spaghetti plot of all patients’

hemodynamic parameter changes at successive time points
after epinephrine pledgets were placed after complete ESS.
No beta-blockers, or other vasodilatory or vasoconstrictive medications were necessary to treat hemodynamic
changes encountered during the current study. There were
no ECG abnormalities in any patients, and no cardiovascular events intraoperatively or postoperatively. Mean EBL
was 75.8 ± 32.2 mL, and there were no major intraoperative
complications such as cerebrospinal fluid leak, orbital
injury, arterial injuries, or severe hemorrhage requiring
transfusion.

Discussion
Topical 1:1000 epinephrine has been shown to be safe and
effective for achieving hemostasis during ESS.5,7,8,10 There
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Figure 3. Spaghetti plots demonstrating changes in intraoperative heart rate (HR), systolic blood pressure (SBP), diastolic blood
pressure (DBP), and mean arterial pressure (MAP) for all patients after placing wrung-out epinephrine pledgets.

are multiple reasons why intranasal application of topical
1:1000 epinephrine via pledgets may not cause significant
hemodynamic changes. There could be limited systemic
absorption of epinephrine due to more local venoconstriction than what is seen with intramuscular or subcutaneous
injections.17 Limited systemic effects could also result
from local epinephrine metabolism by adrenergic neurons,
hepatic metabolism, or opposing pharmacodynamic effects
of general anesthesia.13 While a few studies have shown
plasma levels of epinephrine to increase after topical intranasal application,1,18 studies have yet to demonstrate exactly
how plasma levels rise after nasal pledget placement.
Studies on topical epinephrine absorption have varied considerably in design, with very few assessing topical epinephrine alone,2,3 and none having assessed 1:1000 topical
epinephrine specifically. The current study demonstrated
that placing six wrung-out epinephrine pledgets, or nearly
6 mg of epinephrine,6,12,19 in maximal direct contact with
damaged sinonasal tissue resulted in no significant systemic
hemodynamic changes. These findings reinforce findings
from previous studies that topical 1:1000 epinephrine is
safe to use during sinonasal surgery.
The current study had three key methodologic differences from previous studies on hemodynamic changes after
intranasal topical epinephrine application. First, prior prospective studies on intranasal epinephrine application have
only assessed hemodynamic changes after induction, before

any sinonasal surgery.4,6,12 However, it is important to study
whether injured mucosa and exposed bone could lead to
increased systemic absorption of epinephrine. Interestingly,
not only were there no significant intraoperative elevations
in HR or blood pressure parameters, there were actually
mean decreases in these parameters. Reasons for the relative vasodilatory systemic response could have been due to
lower systemic epinephrine concentrations activating beta-2
receptors,20,21 vasodilatory effects of the general anesthetic,22 or perhaps the absence of surgical stimulation when
pledgets were placed. Also interesting was that the decreases
in hemodynamic parameters were more pronounced after
surgery, compared to parameters measured before surgery.
Preoperative hemodynamic measurements were largely
unchanged at each time point, similar to other studies.4,6
While the reasons for hemodynamic parameter changes in
this study will require further research, it was important
from a clinical perspective to show that epinephrine pledgets never led to significant HR or BP elevations, ECG
abnormalities, or cardiac events, either preoperatively or
intraoperatively. However, this was a small sample size,
and surgeons should still use caution or avoid using topical
epinephrine in patients with significant cardiovascular
disease.4,7,11,12
Second, prior prospective studies assessing hemodynamic changes after intranasal epinephrine have also only
utilized completely saturated pledgets. Yim et al showed
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significant elevations in blood pressure parameters in 6/26
patients studied,12 and Ahmed et al showed that 2/28
patients had significant SBP elevations after placing completely soaked epinephrine pledgets.6 Kuhar et al recently
showed that wrung-out pledgets contained a mean 0.931 mg
of epinephrine,19 which is about half the amount of epinephrine absorbed onto completely saturated pledgets.6,12 This
should lead to less epinephrine delivery to sinonasal mucosa
and less systemic absorption, which should decrease the
risk of hemodynamic changes and cardiovascular events.
The third unique methodologic aspect of this study was
that it included only eosinophilic CRSwNP patients with
significant mucosal inflammation based on severe nasal
polyp burden and high Lund-Mackay scores. Patients also
all underwent complete bilateral ESS. Therefore, patients
had a maximal amount of exposed traumatized tissue in
very inflamed and vascular wound beds, maximizing the
potential effect of topical epinephrine. Yim et al and Ahmed
et al only studied patients undergoing transsphenoidal
surgery for skull base pathology, and excluded patients
with inflammatory disease.6,12 However, rhinologic surgery very frequently involves inflammatory conditions,23
so it is important to appreciate the pharmacodynamic
effects of topical 1:1000 epinephrine in these patients.
Tangbumrungtham et al recently published a study on topical versus injected epinephrine in 40 CRS patients undergoing ESS, 42.5% of whom had nasal polyps, but they did
not study hemodynamic changes.24 In the current study, it
was encouraging to demonstrate no clinically significant
hemodynamic parameter changes in patients undergoing
complete ESS for eosinophilic CRSwNP, but future studies
will be important to corroborate these findings.
This study also showed that wrung-out epinephrine
pledgets provided excellent intraoperative hemostasis in all
cases. The overall mean EBL during ESS was approximately 75 mL, which should be safe in patients undergoing
ESS for CRSwNP, and was similar to the mean EBL in a
systematic review of topical intranasal epinephrine used
during sinonasal and skull base surgery (61.7-67.9 mL).10
Note that no submucosal epinephrine injections were necessary in this study to achieve hemostasis, which brings into
question whether epinephrine injection is needed during
sinonasal surgery. Tangbumrungtham et al recently showed
in a double-blind randomized controlled study that injecting
1:100 000 epinephrine in addition to topical 1:1000 epinephrine provided no added benefit in intraoperative visualization, compared to topical epinephrine alone.24 If topical
epinephrine alone provides adequate hemostasis and visualization, with less potential for hemodynamic changes, perhaps submucosal epinephrine injection causes more risk
than benefit in the majority of sinonasal surgeries.
There were limitations of the study as well. First, a larger
sample size will be necessary to support or refute the findings from this study. However, while the sample size was
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small, it was similar to previous studies,4,6,12,24 and was
adequately powered. A larger study would also be helpful in
analyzing the effects of certain medical comorbidities on
hemodyamic parameters intraoperatively, such as preoperative oral anti-hypertensive use, hepatic or renal dysfunction,
coagulopathy, and thrombocytopenia. Another limitation
was that adequate intraoperative hemostasis was based on
EBL, without grading intraoperative visualization as has
been utilized in prior studies.24,25 However, the low mean
EBL combined with no major intraoperative complications,
suggested that adequate intraoperative visualization was
achieved. Another potential limitation was that arterial lines
were not used, as they were not indicated for the surgeries
performed. Moment-to-moment hemodynamic changes
could have potentially been missed, but measurements were
taken in close succession to minimize this issue. Another
limitation was that the study only assessed short-term
hemodynamic responses to epinephrine pledgets, and one
cannot determine whether there is any potential for persistent hemodynamic effects postoperatively. Future studies
could examine whether some patients are at risk for persistent effects. A final limitation was that patients with significant cardiovascular risk factors were excluded. While this
was felt to be in the best interest of patients, whether topical
epinephrine is safe to use in patients with cardiovascular
comorbidities cannot be determined from the current study.
Caution should therefore still be used by surgeons in
patients with significant cardiovascular disease.

Conclusion
Intranasal application of topical 1:1000 epinephrine via
wrung-out cottonoid pledgets was effective for intraoperative hemostasis, and did not cause clinically significant
alterations in hemodynamic parameters or cardiovascular
events, both before and during ESS in patients with
CRSwNP.
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